AI-generated summary
In a study of rats with crushed inferior alveolar nerves, the authors compared 660-nm and 808-nm photobiomodulation therapy with a control group. They report that the 808-nm group had more axons per square micrometer and better myelination than the control and 660-nm groups. The authors conclude that 808-nm therapy was able to enhance nerve regeneration in this animal model.
- Participants
- 36
- Who or what was studied
- Wistar rats with inferior alveolar nerve crush injury
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The study was conducted in rats, and the abstract reports no human data and does not describe long-term outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 100 J/cm2
- Power
- 70 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.